Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with migraine with or without aura fulfilling the International Classification of Headache Disorders (ICHD)-2.
History of disabling migraine for at least 1 year.
Migraine Disability Assessment Test (MIDAS) score ≥11.
Migraine onset before the age of 50 years.
History of 3-8 migraine attacks per month and \<15 headache days per month during the past 3 months.
You may not be if
Known hypersensitivity to lasmiditan, or to any excipient of lasmiditan oral tablets.
History or evidence of hemorrhagic stroke, epilepsy, or any other condition placing the patient at increased risk of seizures.
History of recurrent dizziness and/or vertigo including benign paroxysmal positional vertigo, Meniere's disease, vestibular migraine, and other vestibular disorders.
History of diabetes mellitus with complications (diabetic retinopathy, nephropathy, or neuropathy).
History of orthostatic hypotension with syncope.
Clareo Health | A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
